- Home
- HTH vs CERT Comparison
HTH vs CERT Comparison
Compare HTH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- CERT
- Stock Information
- Founded
- HTH 1998
- CERT 2008
- Country
- HTH United States
- CERT United States
- Employees
- HTH N/A
- CERT N/A
- Industry
- HTH Major Banks
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- HTH Finance
- CERT Technology
- Exchange
- HTH Nasdaq
- CERT Nasdaq
- Market Cap
- HTH 2.1B
- CERT 1.9B
- IPO Year
- HTH 2004
- CERT 2020
- Fundamental
- Price
- HTH $31.28
- CERT $11.58
- Analyst Decision
- HTH Hold
- CERT Buy
- Analyst Count
- HTH 3
- CERT 7
- Target Price
- HTH $34.50
- CERT $15.92
- AVG Volume (30 Days)
- HTH 230.1K
- CERT 1.3M
- Earning Date
- HTH 01-23-2025
- CERT 11-06-2024
- Dividend Yield
- HTH 2.18%
- CERT N/A
- EPS Growth
- HTH N/A
- CERT N/A
- EPS
- HTH 1.63
- CERT N/A
- Revenue
- HTH $1,169,826,000.00
- CERT $372,797,000.00
- Revenue This Year
- HTH N/A
- CERT $10.20
- Revenue Next Year
- HTH $0.79
- CERT $10.43
- P/E Ratio
- HTH $19.13
- CERT N/A
- Revenue Growth
- HTH N/A
- CERT 5.62
- 52 Week Low
- HTH $28.58
- CERT $9.41
- 52 Week High
- HTH $35.66
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- HTH 44.12
- CERT 55.62
- Support Level
- HTH $31.01
- CERT $11.05
- Resistance Level
- HTH $32.04
- CERT $11.83
- Average True Range (ATR)
- HTH 0.61
- CERT 0.50
- MACD
- HTH -0.08
- CERT 0.06
- Stochastic Oscillator
- HTH 10.83
- CERT 63.87
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. Its primary line of business is to provide business and consumer banking services from offices throughout Texas through the PlainsCapital Bank. The company also provides other financial products and services through its broker-dealer and mortgage origination segments. The company generates a majority of its revenue through its banking operations.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.